BIOPHARMAGRADE
Live / Registered — Registered (as of 26 Jan 2021)
What this means for you
Registered since 26 Jan 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 26 Jan 2027, and its filing window is open now).
Record
- Serial number
- 87571868
- Registration number
- 6257470
- Mark type
- Word mark
- Filed
- 16 Aug 2017
- Published for opposition
- 20 Aug 2019
- Registered
- 26 Jan 2021
- Next maintenance filing
- §8 declaration of use, due by 26 Jan 2027 (grace period to 26 Jul 2027)
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 042 — Scientific and technological services: Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
Owner
- Pfanstiehl, Inc., Waukegan, IL
- Pfanstiehl, Inc., Waukegan, IL
- Pfanstiehl, Inc., Waukegan, IL
Prosecution history
- 26 Jan 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Dec 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Dec 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Dec 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Dec 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Oct 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Oct 2020 — NON-FINAL ACTION E-MAILED
- 27 Oct 2020 — SU - NON-FINAL ACTION - WRITTEN
- 06 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Sept 2020 — USE AMENDMENT FILED
- 05 Oct 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Sept 2020 — TEAS STATEMENT OF USE RECEIVED
- 19 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED